Olivier Delattre

Institut Curie — France

Medicine · Health Sciences

113h-index53.6kcitations1.2kworks1.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neuroblastoma Research and Treatments(318), Sarcoma Diagnosis and Treatment(240), Cancer Genomics and Diagnostics(146), Cancer, Hypoxia, and Metabolism(111), Chromatin Remodeling and Cancer(98)

Publications1.2k total

Abstract PR002: Domain-specific oncogenic functions of VGLL2::NCOA2 in infantile rhabdomyosarcoma
Cancer Research·2026
The hegemonic EWSR1::ETS oncoprotein overrules core regulatory circuitry principles in Ewing sarcoma
npj Precision Oncology·2025Open Access
Figure S3 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
2025Open Access
Figure S5 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
2025Open Access
Supplementary Data DS1 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
2025Open Access
Figure S6 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
2025Open Access
Figure S4 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
2025Open Access
Figure S2 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
2025Open Access
Figure S1 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
2025Open Access
Interest of a sequential multimodal approach for the treatment of newly diagnosed patients with multimetastatic Ewing sarcoma: results of the French prospective CombinaiR3 phase II trial
British Journal of Cancer·2025Open Access
Harmonization of Reporting of ALK Genetic Alterations in Neuroblastoma
Journal of Molecular Diagnostics·2025Open Access
Abstract B048: The Ewing Sarcoma Institute – a catalyst to improve outcomes for patients with Ewing sarcoma globally
Cancer Research·2025
Advancing Preclinical Biology for Ewing Sarcoma: An International Effort
Molecular Cancer Therapeutics·2025· 1 citedOpen Access
Small round cell sarcoma tumoroid biobank reveals CIC::DUX4 sarcoma vulnerability to MCL-1 inhibition
Nature Communications·2025· 4 citedOpen Access
Scandare: A Successful, Flexible, Prospective, and Longitudinal Biobank Framework
2025Open Access
Label‐Free Machine Learning Prediction of Chemotherapy on Tumor Spheroids Using a Microfluidics Droplet Platform
Small Science·2025· 1 citedOpen Access
Author Correction: Class I HDAC inhibitors enhance YB-1 acetylation and oxidative stress to block sarcoma metastasis
EMBO Reports·2025Open Access
Abstract 3947: Defining VGLL2::NCOA2 and ARF6 cooperation in infantile rhabdomyosarcoma
Cancer Research·2025
Abstract 3946: VGLL2::NCOA2 structure-function analysis reveals domain requirements for fusion-driven infantile rhabdomyosarcoma
Cancer Research·2025
Label-free Machine Learning Prediction of Chemotherapy on Tumor Spheroids using a Microfluidics Droplet Platform
2025Open Access
page 1 of 61Next →

Frequent Co-authors

Gilles Thomas(8), Isabelle Janoueix‐Lerosey(8), Gaëlle Pierron(8), Jessica Zucman‐Rossi(7), Alain Aurias(7), Marcel Kool(7), Franck Bourdeaut(7), Franck Tirode(7), Gudrun Schleiermacher(6), Jean Michon(6), Didier Surdez(5), Xavier Sastre‐Garau(5), Andrey Korshunov(5), Marc Remke(5), Paul A. Northcott(5), Stefan M. Pfister(5), Thomas G. P. Grünewald(5), Poul H. Sorensen(5), Chantal Desmaze(4), Thomas Melot(4)